Grant Funds Research On Inflammation, Kidney Disease And Cardiovascular Disease, USA
Chronic kidney disease and atherosclerotic cardiovascular disease share common antecedents, and markers of inflammation have emerged as highly predictive of atherosclerotic cardiovascular disease events in persons without chronic kidney disease. However, according to Erlinger, the prospective role of inflammation in the setting of moderately impaired renal function has received scant attention.
Erlinger plans to assess the role of inflammation on chronic kidney disease progression and on the occurrence of atherosclerotic cardiovascular disease events using specimens collected as part of the African-American Study of Kidney Disease and Hypertension study.
"Ultimately, results of this study should enhance our understanding of risk factors and processes that determine the progression of kidney disease and the risk of cardiovascular disease among African-Americans with hypertension," said Erlinger. "Such results might eventually lead to new strategies that delay or prevent end-stage kidney disease and its complications."
The University of Texas Medical Branch at Galveston
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Texas Medical Branch. "Grant Funds Research On Inflammation, Kidney Disease And Cardiovascular Disease, USA." Medical News Today. MediLexicon, Intl., 26 Oct. 2007. Web.
25 Feb. 2017. <http://www.medicalnewstoday.com/releases/86770.php>
University of Texas Medical Branch. (2007, October 26). "Grant Funds Research On Inflammation, Kidney Disease And Cardiovascular Disease, USA." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.